Search
Project Funding Partners
Pfizer-CDRD Innovation Fund
Pfizer Canada has provided $3 million to the Centre for Drug Research and Development to launch a fund aimed at accelerating the commercialization of some of BC’s most promising academic research projects into high-value medicines that form the basis for new companies or licensing opportunities. This fund leverages an additional $1 million for innovation projects from the NCE Centres of Excellence in Commercialization and Research, bringing total CDRD Innovation project funding to $4 million.
The fund is administered by CDRD based on the recommendations of an expert review panel and is aimed at helping researchers overcome the costly gap between discovery and commercialization.
Genome BC–CDRD Development Fund
The Genome BC–CDRD Development Fund was created to accelerate the development of commercially promising projects related to advances and discoveries stemming from genome sciences and genetics. Genome BC has earmarked $1 million toward the fund on a project-by-project basis. CDRD will contribute up to $1 million in expertise, facilities, and equipment time.
Western Canada Innovation Agreement
The Western Canada Innovation Agreement brings together CDRD, the Province of British Columbia, the Province of Alberta, and Johnson &Johnson Corporate Office of Science and Technology (COSAT) to jointly develop and manage a fund to support innovative health research programs in the life sciences sector.
The agreement provides for a joint steering committee that will oversee a co-managed seed fund to enable early-stage, smart discoveries within the health sciences so that they may advance along a pathway to commercialization. Representatives from Alberta, British Columbia/CDRD and COSAT will jointly assess opportunities for the collaboration, funding, management, and commercialization of innovative health research projects.